The Effects of Opt-out vs Opt-in Tobacco Treatment on Engagement, Cessation, and Costs

Abstract

ImportanceTobacco use causes 7 million deaths per year; most national guidelines require people who use tobacco to opt in to care by affirming they are willing to quit. Use of medications and counseling is low even in advanced economy countries.ObjectiveTo evaluate the efficacy of opt-out care vs opt-in care for people who use tobacco.Design, Setting, and ParticipantsIn Changing the Default (CTD), a Bayesian adaptive population-based randomization trial, eligible patients were randomized into study groups, treated according to group assignment, and debriefed and consented for participation at 1-month follow-up. A total of 1000 adult patients were treated at a tertiary care hospital in Kansas City. Patients were randomized from September 2016 to September 2020; final follow-up was in March 2021.InterventionsAt bedside, counselors screened for eligibility, conducted baseline assessment, randomized patients to study group, and provided opt-out care or opt-in care. Counselors and medical staff provided opt-out patients with inpatient nicotine replacement therapy, prescriptions for postdischarge medications, a 2-week medication starter kit, treatment planning, and 4 outpatient counseling calls. Patients could opt out of any or all elements of care. Opt-in patients willing to quit were offered each element of treatment described previously. Opt-in patients who were unwilling to quit received motivational counseling.Main Outcomes and MeasuresThe main outcomes were biochemically verified abstinence and treatment uptake at 1 month after randomization.ResultsOf a total of 1000 eligible adult patients who were randomized, most consented and enrolled (270 [78%] of opt-in patients; 469 [73%] of opt-out patients). Adaptive randomization assigned 345 (64%) to the opt-out group and 645 (36%) to the opt-in group. The mean (SD) age at enrollment was 51.70 (14.56) for opt-out patients and 51.21 (14.80) for opt-out patients. Of 270 opt-in patients, 123 (45.56%) were female, and of 469 opt-out patients, 226 (48.19%) were female. Verified quit rates for the opt-out group vs the opt-in group were 22% vs 16% at month 1 and 19% vs 18% at 6 months. The Bayesian posterior probability that opt-out care was better than opt-in care was 0.97 at 1 month and 0.59 at 6 months. Treatment use for the opt-out group vs the opt-in group was 60% vs 34% for postdischarge cessation medication (bayesian posterior probability of 1.0), and 89% vs 37% for completing at least 1 postdischarge counseling call (bayesian posterior probability of 1.0). The incremental cost-effectiveness ratio was $678.60, representing the cost of each additional quit in the opt-out group.Conclusions and RelevanceIn this randomized clinical trial, opt-out care doubled treatment engagement and increased quit attempts, while enhancing patients’ sense of agency and alliance with practitioners. Stronger and longer treatment could increase cessation.Trial RegistrationClinicalTrials.gov Identifier: NCT02721082

Are behavioral economics interventions effective in increasing colorectal cancer screening uptake: A systematic review of evidence and meta-analysis?

“…A study in Canada found that with the introduction of the opt-out method, HIV testing rates increased [ 64 ]. Richter et al [ 65 ] revealed the opt-out strategy folded treatment involvement and increased quit efforts. A study exhibited that opt-out protocol resulted in harmless discontinuation of antibiotics in patients with suspected sepsis [ 66 ].…”

Persistent High Smoking Prevalence in a Swiss Psychiatric Hospital between 2001 and 2020 despite Smoking Bans and Perspectives for Further Necessary Interventions

“…Other strategies allowing to include smokers unmotivated or ambivalent about cessation include opt-out procedures. Opt-out care can double engagement in tobacco treatment and increase quit rates (Richter et al, 2023). All these strategies could attract smokers not really ready to quit or those never having considered it previously, and allow a preparation period to quitting or a triggering event leading to cessation.…”

Implementation of an “Opt-Out” Tobacco Treatment Program in Six Hospitals in South Carolina

“…The United States Department of Health and Human Services recently requested information on strategies to broaden the delivery of evidence-based smoking cessation treatments to those who continue to smoke cigarettes (18). Previous studies have demonstrated the effectiveness of an opt-out smoking cessation treatment model for hospitalized patients (5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15). This study is unique in that it examines practical feasibility of implementing an opt-out smoking cessation treatment model across multiple hospitals serving diverse patient populations.…”